THERANOSTICTRIALS.ORG

Serial Number 98838219
694

Registration Progress

Application Filed
Nov 5, 2024
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

THERANOSTICTRIALS.ORG

Basic Information

Serial Number
98838219
Filing Date
November 5, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
694
Status Date
Dec 9, 2025
Application
Pending
Classes
042

Rights Holder

Xcancer Software, LLC

16
Address
17607 Gold Plaza
Omaha, NE 68130

Ownership History

Xcancer Software, LLC

Original Applicant
16
Omaha, NE

Legal Representation

Attorney
Roberta L. Christensen

USPTO Deadlines

Next Deadline
2184 days remaining
Section 8 Declaration Due (Supplemental Register) (Based on registration date 20251216)
Due Date
December 16, 2031
Grace Period Ends
June 16, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

13 events
Date Code Type Description Documents
Dec 9, 2025 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY Loading...
Nov 18, 2025 CNTA O APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER Loading...
Nov 14, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 14, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 14, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 27, 2025 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Oct 27, 2025 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Jul 27, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 27, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jul 27, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 7, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 6, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 5, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Providing a hub through a website for patients, healthcare professionals, pharmaceuticals companies, product manufacturers, patient advocates, regulatory agencies, cancer centers, research and development institutions, radioactive courier services, staffing companies, and investors to meet, expand awareness, and share their capabilities in the field of cancer research and treatment; providing access to an online listing of cancer trials and educational materials in the field of cancer research and treatment
First Use Anywhere: 20220900
First Use in Commerce: 20220900

Additional Information

Pseudo Mark
THERANOSTIC TRIALS

Classification

International Classes
042